To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
JLL to acquire pharmaceutical developer
The New York-based private equity firm will purchase the outstanding shares of PharmaNet Development Group for $5 a share in a deal valued at close to $100 million.
